QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.54
−2.95%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.36
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.44
- EPS estimate
- -$0.46
- Revenue actual
- —
- Revenue estimate
- $750.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +145.4%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $44
- PT range
- $34 – $66
- Analysts
- 4
4 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.46 | -$0.44 | Beat 4.34% | — |
| May 5, 2026 | -$0.52 | -$0.54 | Miss -3.85% | — |
| Mar 10, 2026 | -$0.86 | $3.65 | Beat 524.42% | $53.7M |
| Nov 13, 2025 | -$1.39 | -$0.60 | Beat 56.83% | — |
| Aug 6, 2025 | -$1.14 | -$0.78 | Beat 31.58% | — |
| May 8, 2025 | -$1.23 | -$0.90 | Beat 26.83% | — |
| Mar 11, 2025 | -$1.25 | -$1.16 | Beat 7.20% | — |
| Nov 7, 2024 | -$1.41 | -$1.46 | Miss -3.55% | — |
| May 9, 2024 | -$1.42 | -$13 | Miss -826.06% | — |
| Mar 13, 2024 | -$0.30 | -$0.28 | Beat 6.67% | -$14.7M |
| Nov 14, 2023 | -$0.42 | -$0.57 | Miss -35.71% | $1.9M |
| Jul 27, 2023 | -$8.55 | -$11 | Miss -28.42% | $354.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026